Statistical Significance and Biological Relevance

EFSA Journal

Volumn 9, Issue 9, 2011, Pages

[No Author Info available]

Author keywords

biological relevance; Statistical significance

Indexed keywords

EID: 85053203545     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2011.2372     Document Type: Article

References (19)

1. Alderson P, 2004. Absence of evidence is not evidence of absence (Editorial). British Medical Journal, 328, 476–477.
2. Altman DG, Gore SM, Gardner MJ, Pocock SJ, 1983. Statistical guidelines for contributors to medical journals. British Medical Journal, 286(6376), 1489–1493.
3. Altman DG & Bland JM, 1995. Statistics notes: Absence of evidence is not evidence of absence. British Medical Journal, 311, 485.
4. Bauer P, 1991. Multiple testing in clinical trials. Statistics in Medicine, 10(6), 871–890.
5. Chatfield C, 2002. Confessions of a Pragmatic Statistician. The Statistician, 51, 1–20.
6. Chatfield C, 1985. The Initial Examination of Data. Journal of the Royal Statistical Society, Series A, 148(3), 214–253.
7. EFSA, 2009a. Guidance of the Scientific Committee on a request from EFSA on the use of the benchmark dose approach in risk assessment. EFSA Journal 2009, 1150, 1–72.
8. EFSA, 2009b. Scientific opinion on Statistical considerations for the safety evaluation of GMOs. EFSA Journal 2010, 8(1), 1250.
9. Gardner MJ & Altman DG, 1986. Confidence intervals rather than P values: estimation rather than hypothesis testing. British Medical Journal, 292, 746–750.
10. Hollon SD, Flick SN, 1988. On the meaning of clinical significance. Behavioural Assessment, 10(2), 197–206.
11. Killoy WJ, 2002. The clinical significance of local chemotherapies. Journal of Clinical Periodontology, 29, Issue Supplement s2, 6–13.
12. Lee PN, Lovell D, 2009. Statistics for toxicology; General and Applied Toxicology, Third Edition, John Wiley & Sons, Ltd.
13. LeFort SM, 1993. The Statistical versus Clinical Significance Debate. Journal of Nursing Scholarship, 25, 57–62.
14. Lindgren BR, Wielinskyi CL, Finkelstein SM, Warwick WJ, 1993. Contrasting clinical and statistical significance within the research setting. Pediatric Pulmonology, 16, 336–340.
15. Luus HG, Muller FO, Meyer BH, 1989. Statistical significance versus clinical relevance; part 1; the essential role of the power of a statistical test. South African Medical Journal, 78, 568–70.
16. NRC, 2007. Toxicity testing in the 21st Century: A Vision and a Strategy. The National Academies Press.
17. OECD, 2007. Guidelines for the Testing of Chemicals: Revised and new guidelines adopted 2007. Reese RA, 2004. Does significance matter? Significance, 1(1) 39–40.
18. Shuirmann DJ, 1987. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. Journal of Pharmacokinetics and Biopharmaceutics, 15(6), 657–680.
19. Sterne JA, Davey Smith G, 2001. Sifting the evidence-what's wrong with significance tests? British Medical Journal, 322, 226–231